Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             138 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormalities of retinoblastoma gene structure in human lung tumors 1994
 11 1-2 p. 131-
1 p.
 artikel
2 A case-control study of malignant and non-malignant respiratory disease among employees of a fibreglass manufacturing facility. II Exposure assessment 1994
 11 1-2 p. 127-128
2 p.
 artikel
3 Activation of potassium channels by hypoxia and reoxygenation in the human lung adenocarcinoma cell line A549 1994
 11 1-2 p. 132-
1 p.
 artikel
4 Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer: Results of a randomized prospective study 1994
 11 1-2 p. 147-148
2 p.
 artikel
5 Alteration in length of telomeric repeats in lung cancer Shirotani, Yoshifumi
 1994
 11 1-2 p. 29-41
13 p.
 artikel
6 Altered topoisomerase IIα in a drug-resistant small cell lung cancer cell line selected in VP-16 1994
 11 1-2 p. 143-
1 p.
 artikel
7 Announcement 1994
 11 1-2 p. 120-121
2 p.
 artikel
8 A Phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer 1994
 11 1-2 p. 145-146
2 p.
 artikel
9 A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer 1994
 11 1-2 p. 143-
1 p.
 artikel
10 Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type 1994
 11 1-2 p. 123-124
2 p.
 artikel
11 Association of dissociation of a protease and its inhibitor on the surface of lung squamous cell carcinoma cells 1994
 11 1-2 p. 132-
1 p.
 artikel
12 Association of military lung metastases and bone metastases in bronchogenic carcinoma 1994
 11 1-2 p. 137-
1 p.
 artikel
13 A study of tobacco carcinogenesis. LI. Relative potencies of tobacco-specific N-nitrosamines as inducers of lung tumours in A/J mice 1994
 11 1-2 p. 128-
1 p.
 artikel
14 A survey of primary lung cancer among NTT workers in the Tokyo area. The incidence and mortality during the past 30 years and significance of radiologic screening 1994
 11 1-2 p. 126-
1 p.
 artikel
15 Biological markers in smoking cessation treatment 1994
 11 1-2 p. 124-125
2 p.
 artikel
16 Bone marrow haemosiderin iron and serum iron status markers in small cell carcinoma of the lung 1994
 11 1-2 p. 136-
1 p.
 artikel
17 Bronchogenic cancer associated with head and neck tumors: Survival analysis of 194 patients 1994
 11 1-2 p. 138-
1 p.
 artikel
18 Bronchogenic cancer in patients under 40 years old: The experience of a Latin American country 1994
 11 1-2 p. 134-135
2 p.
 artikel
19 Bronchoscopic diathermy resection and stent insertion: A cost effective treatment for tracheobronchial obstruction 1994
 11 1-2 p. 139-
1 p.
 artikel
20 Bronchoscopic treatment of lung tumors Sutedja, G.
 1994
 11 1-2 p. 1-17
17 p.
 artikel
21 C2+ and Ca2+ channel antagonists in the control of human small cell lung carcinoma cell proliferation 1994
 11 1-2 p. 140-
1 p.
 artikel
22 Carboplatin, etoposide, and radiotherapy, followed by surgery, for the treatment of marginally resectable non-small cell lung cancer 1994
 11 1-2 p. 148-
1 p.
 artikel
23 Carboplatin plus epirubicin plus VP-16, concurrent ‘split course’ radiotherapy and adjuvant surgery for limited small cell lung cancer Gridelli, Cesare
 1994
 11 1-2 p. 83-91
9 p.
 artikel
24 Case report: Oat cell cancer and renal failure 1994
 11 1-2 p. 138-
1 p.
 artikel
25 Changes in lung function and perfusion after irradiation in patients with lung cancer Abratt, Raymond P.
 1994
 11 1-2 p. 61-69
9 p.
 artikel
26 Characterisation of human tumour cell lines using antibodies to intermediate filaments 1994
 11 1-2 p. 133-
1 p.
 artikel
27 Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough? 1994
 11 1-2 p. 142-143
2 p.
 artikel
28 Chemotherapy outcomes in advanced non-small-cell lung carcinoma 1994
 11 1-2 p. 146-
1 p.
 artikel
29 Childhood primary pulmonary neoplasms 1994
 11 1-2 p. 137-
1 p.
 artikel
30 Chromosome abnormalities in non-small cell lung cancer pleural effusions: Cytogenetic indicators of disease subgroups 1994
 11 1-2 p. 134-
1 p.
 artikel
31 Chronic oral etoposide in small-cell lung cancer: Clinical and pharmacokinetic results 1994
 11 1-2 p. 145-
1 p.
 artikel
32 Cigarette smoking is a determinant of DT-diaphorase gene expression in human non-small cell lung carcinoma 1994
 11 1-2 p. 123-
1 p.
 artikel
33 Cis-diamminedichloroplatnium(II) inhibits p34(cdc2) protein kinase in human lung-cancer cells 1994
 11 1-2 p. 141-
1 p.
 artikel
34 Combination effect of nevalbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice 1994
 11 1-2 p. 141-142
2 p.
 artikel
35 Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains 1994
 11 1-2 p. 128-
1 p.
 artikel
36 Comparison of response evaluation in small cell lung cancer using computerized tomography and chest radiography Dajczman, Esther
 1994
 11 1-2 p. 51-60
10 p.
 artikel
37 Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer 1994
 11 1-2 p. 136-
1 p.
 artikel
38 Current perspectives in the treatment of small cell lung cancer 1994
 11 1-2 p. 148-149
2 p.
 artikel
39 CVM versus ACE in the treatment of small cell lung cancer 1994
 11 1-2 p. 140-
1 p.
 artikel
40 Detailed characterization of a high-molecular-weight glycoprotein secreted by lung cancer cells 1994
 11 1-2 p. 130-
1 p.
 artikel
41 Development of chemopreventive agents for lung and upper aerodigestive tract cancers 1994
 11 1-2 p. 124-
1 p.
 artikel
42 Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines 1994
 11 1-2 p. 129-
1 p.
 artikel
43 Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: A placebo-controlled randomized phase Ib study 1994
 11 1-2 p. 140-141
2 p.
 artikel
44 Early squamous lung cancer and longer survival rates 1994
 11 1-2 p. 133-134
2 p.
 artikel
45 Editorial Board 1994
 11 1-2 p. IFC-
1 p.
 artikel
46 Endobronchial metastasis 1994
 11 1-2 p. 136-
1 p.
 artikel
47 Etoposide-resistant human colon and lung adenocarcinoma cell lines exhitib sensitivity to homoharringtonine 1994
 11 1-2 p. 141-
1 p.
 artikel
48 Expression of carbohydrate antigens in human pulmonary adenocarcinoma 1994
 11 1-2 p. 131-132
2 p.
 artikel
49 Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study 1994
 11 1-2 p. 146-147
2 p.
 artikel
50 Extensive small cell lung cancer 1994
 11 1-2 p. 149-
1 p.
 artikel
51 Extensive small cell lung cancer: Trials of Indiana University and the Hoosier Oncology Group 1994
 11 1-2 p. 149-
1 p.
 artikel
52 Factors influencing response to second-line treatment with teniposide (VM26) in patients with progressive small cell lung cancer (SCLC) 1994
 11 1-2 p. 146-
1 p.
 artikel
53 Future directions in the management of non-small cell lung cancer 1994
 11 1-2 p. 150-
1 p.
 artikel
54 Genetic changes in lung cancer 1994
 11 1-2 p. 130-131
2 p.
 artikel
55 High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages 1994
 11 1-2 p. 129-130
2 p.
 artikel
56 IASLC calendar 1994
 11 1-2 p. 122-
1 p.
 artikel
57 Ifosfamide/carboplatin/etoposide (ICE) regimen in small cell lung cancer 1994
 11 1-2 p. 144-
1 p.
 artikel
58 Immune response induced in small-cell lung cancer by maintenance therapy with interferon gamma 1994
 11 1-2 p. 134-
1 p.
 artikel
59 Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: The role in cancer progression 1994
 11 1-2 p. 133-
1 p.
 artikel
60 Increased risk of lung cancer in Japanese smokers with class mu glutathione S-transferase gene deficiency 1994
 11 1-2 p. 128-
1 p.
 artikel
61 Induction of lung and liver tumors by fluoranthene in a preweanling CD-1 mouse bioassay 1994
 11 1-2 p. 127-
1 p.
 artikel
62 Interferon therapy in lung cancer 1994
 11 1-2 p. 140-
1 p.
 artikel
63 Interruption of aortic flow between the thoracic and abdominal aorta with development of collateral circulation secondary to bronchogenic carcinoma 1994
 11 1-2 p. 137-
1 p.
 artikel
64 Intradural parenchymalinvolvement in the spinal subarachnoid space associated with primary lung cancer 1994
 11 1-2 p. 135-
1 p.
 artikel
65 IR-192, low dose rate endobronchial brachytherapy in the treatment of malignant airway obstruction 1994
 11 1-2 p. 148-
1 p.
 artikel
66 Is there a role for vindesine in the treatment of non-small cell lung cancer? 1994
 11 1-2 p. 144-
1 p.
 artikel
67 Japanese doctors' preferred treatment choices for their hypothetical non-small cell lung cancer: how they would wish to be treated Motohiro, Akira
 1994
 11 1-2 p. 43-50
8 p.
 artikel
68 K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma Li, Shanrong
 1994
 11 1-2 p. 19-27
9 p.
 artikel
69 Levels of complement regulatory molecules in lung cancer: Disappearance of the D17 epitope of CD55 in small-cell carcinoma 1994
 11 1-2 p. 132-133
2 p.
 artikel
70 Limited small-cell lung carcinoma: High complete response rate and survival with short intensive chemotherapy and extensive irradiation. Results of a pilot study 1994
 11 1-2 p. 144-145
2 p.
 artikel
71 Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET 1994
 11 1-2 p. 137-138
2 p.
 artikel
72 Lung tumors in strain A mice: Application for studies in cancer chemoprevention 1994
 11 1-2 p. 124-
1 p.
 artikel
73 Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues 1994
 11 1-2 p. 126-
1 p.
 artikel
74 Metastatic non-small cell lung cancer 1994
 11 1-2 p. 150-
1 p.
 artikel
75 Molecular epidemiology of lung cancer and the modulation of markers of chronic carcinogen exposure by chemopreventive agents 1994
 11 1-2 p. 131-
1 p.
 artikel
76 Monoclonal antibody KP16D3 as a prognostic marker in stage I lung adenocarcinoma 1994
 11 1-2 p. 136-
1 p.
 artikel
77 Mortality from lung cancer in Ontario uranium miners 1994
 11 1-2 p. 125-
1 p.
 artikel
78 Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer: Impact of preoperative chemotherapy on resectability and downstaging 1994
 11 1-2 p. 147-
1 p.
 artikel
79 Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: A phase III randomized study conducted by the European lung cancer working party 1994
 11 1-2 p. 143-
1 p.
 artikel
80 Near-haploid karyotype in a squamous cell lung carcinoma 1994
 11 1-2 p. 139-
1 p.
 artikel
81 Neglected lung cancer Madjar, Shahar
 1994
 11 1-2 p. 105-109
5 p.
 artikel
82 Neural cell adhesion molecule and prognosis of surgically resected lung cancer 1994
 11 1-2 p. 135-
1 p.
 artikel
83 Neuron-specific enolase and CYFRA 21-1 in lung cancers 1994
 11 1-2 p. 135-
1 p.
 artikel
84 News from the editor Hansen, Heine H.
 1994
 11 1-2 p. 119-
1 p.
 artikel
85 New treatment opportunities in non-small cell lung cancer 1994
 11 1-2 p. 150-
1 p.
 artikel
86 Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma 1994
 11 1-2 p. 128-129
2 p.
 artikel
87 N-isopropyl-p-iodoamphetamine receptors in normal and cancerous tissue of the human lung 1994
 11 1-2 p. 132-
1 p.
 artikel
88 Occupational risk factors for lung cancer among nonsmoking women: A case-control study in Missouri (United States) 1994
 11 1-2 p. 126-
1 p.
 artikel
89 Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: Implications for the design of future non-small-cell lung cancer combined modality trials 1994
 11 1-2 p. 144-
1 p.
 artikel
90 ‘Patient-like’ nude- and SCID-mouse models of human lung and pleural cancer (review) 1994
 11 1-2 p. 148-
1 p.
 artikel
91 Pharmacokinetics of cisplatin instilled into the pleural cavity following panpleuropneumonectomy in patients with malignant pleurisy due to lung cancer 1994
 11 1-2 p. 136-
1 p.
 artikel
92 Phase I clinical and pharmacokinetic study of a 14-day infusion of etoposide in patients with lung cancer 1994
 11 1-2 p. 147-
1 p.
 artikel
93 Phase II study of carboplatin, cisplatin, and vindesine in advanced non-small-cell lung cancer 1994
 11 1-2 p. 141-
1 p.
 artikel
94 Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin- etoposide hybrid chemotherapy in small cell lung cancer 1994
 11 1-2 p. 145-
1 p.
 artikel
95 Platinum-based chemotherapy for inoperable non-small cell lung cancer: a real therapeutic progress? Buccheri, Gianfranco
 1994
 11 1-2 p. 115-117
3 p.
 artikel
96 p53 Protein accumulates frequently in early bronchial neoplasia 1994
 11 1-2 p. 130-
1 p.
 artikel
97 Preoperative chemotherapy for locally advanced non-small cell lung cancer 1994
 11 1-2 p. 147-
1 p.
 artikel
98 Previous cancer and radiotherapy as risk factors for lung cancer in lifetime nonsmokers 1994
 11 1-2 p. 127-
1 p.
 artikel
99 Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer 1994
 11 1-2 p. 139-140
2 p.
 artikel
100 Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients 1994
 11 1-2 p. 131-
1 p.
 artikel
101 Prognostic significance of flow cytometry in non-small-cell lung cancer 1994
 11 1-2 p. 138-
1 p.
 artikel
102 Protease inhibitors suppress in vitro growth of human small cell lung cancer 1994
 11 1-2 p. 130-
1 p.
 artikel
103 Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer 1994
 11 1-2 p. 141-
1 p.
 artikel
104 Pulmonary perfusion scan in the evaluation of the local extension in lung cancer 1994
 11 1-2 p. 137-
1 p.
 artikel
105 Pulmonary resection after pneumonectomy in patients with bronchogenic carcinoma 1994
 11 1-2 p. 139-
1 p.
 artikel
106 Quantitative importance of asbestos as a cause of lung cancer in a Swedish industrial city: A case-referent study 1994
 11 1-2 p. 125-126
2 p.
 artikel
107 Radioimmunodetection of human small cell lung carcinoma xenografts in the nude rat using 111In-labelled monoclonal antibody MOC-31 1994
 11 1-2 p. 130-
1 p.
 artikel
108 Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B 1994
 11 1-2 p. 146-
1 p.
 artikel
109 Rationale for the treatment of non-small cell lung cancer 1994
 11 1-2 p. 150-
1 p.
 artikel
110 Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo 1994
 11 1-2 p. 142-
1 p.
 artikel
111 Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapy 1994
 11 1-2 p. 142-
1 p.
 artikel
112 Rising lung cancer mortality in the United States, 1968–1988: The manifestation of altered disease competition 1994
 11 1-2 p. 123-
1 p.
 artikel
113 Risk factors of lung cancer by histological category in Taiwan 1994
 11 1-2 p. 123-
1 p.
 artikel
114 Risk of late recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC) Szczepek, Barbara
 1994
 11 1-2 p. 93-104
12 p.
 artikel
115 Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors 1994
 11 1-2 p. 129-
1 p.
 artikel
116 Satellite PET and lung cancer: A prospective study in surgical patients 1994
 11 1-2 p. 134-
1 p.
 artikel
117 Saturated fat intake and lung cancer risk among nonsmoking women in Missouri 1994
 11 1-2 p. 125-
1 p.
 artikel
118 Self-expandable metallic stent therapy for superior vena cava syndrome: Clinical observations 1994
 11 1-2 p. 135-
1 p.
 artikel
119 Sensory disorder of the chest as presenting symptom of lung cancer 1994
 11 1-2 p. 137-
1 p.
 artikel
120 Statistical design and monitoring of the carotene and retinol efficacy trial (CARET) 1994
 11 1-2 p. 124-
1 p.
 artikel
121 Strategies for new drug identification in small cell lung cancer 1994
 11 1-2 p. 143-144
2 p.
 artikel
122 Survival rates in lung cancer patients with and without bronchial asthma 1994
 11 1-2 p. 135-
1 p.
 artikel
123 The cellular and molecular basis of the ectopic ACTH syndrome 1994
 11 1-2 p. 138-
1 p.
 artikel
124 The lymphatic pathways of non-small cell lung cancer and their implication in curative irradiation treatment Kiricuta, I.C.
 1994
 11 1-2 p. 71-82
12 p.
 artikel
125 The MIC regimen in non-small cell lung cancer 1994
 11 1-2 p. 145-
1 p.
 artikel
126 The presence of mutagens/carcinogens in the excised lung and analysis of lung cancer induction 1994
 11 1-2 p. 127-
1 p.
 artikel
127 The role of colony-stimulating factors in small cell lung cancer 1994
 11 1-2 p. 149-
1 p.
 artikel
128 The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer 1994
 11 1-2 p. 137-
1 p.
 artikel
129 Thoracoscopic mediastinal lymph node sampling: Useful for mediastinal lymph node stations inaccessible by cervical mediastinoscopy 1994
 11 1-2 p. 139-
1 p.
 artikel
130 Transcription of somatostatin receptor subtype 1 and 2 genes in lung cancer Thomas, F.
 1994
 11 1-2 p. 111-114
4 p.
 artikel
131 Transfer and expression of the human interleukin-4 gene in carcinoma and stromal cell lines derived from lung cancer patients 1994
 11 1-2 p. 129-
1 p.
 artikel
132 Treatment of elderly patients with small cell lung cancer 1994
 11 1-2 p. 149-
1 p.
 artikel
133 Treatment of limited-stage small cell lung cancer: Recent progress and future directions 1994
 11 1-2 p. 149-150
2 p.
 artikel
134 Treatment of locally advanced non-small cell lung cancer 1994
 11 1-2 p. 150-
1 p.
 artikel
135 Treatment options for patients with relapsed small cell lung cancer 1994
 11 1-2 p. 149-
1 p.
 artikel
136 Two bombesin analogues discriminate between neuromedin B- and bombesin-induced calcium flux in a lung cancer cell line 1994
 11 1-2 p. 133-
1 p.
 artikel
137 Voltage-activated K+ conductance and cell proliferation in small-cell lung cancer 1994
 11 1-2 p. 132-
1 p.
 artikel
138 Y chromosome loss and rearrangement in non-small-cell lung cancer 1994
 11 1-2 p. 133-
1 p.
 artikel
                             138 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland